HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
1. HilleVax is proposed to be sold to XOMA Royalty Corporation. 2. Shareholders will receive $1.95 cash per share plus contingent rights. 3. Kahn Swick & Foti law firm is investigating the deal's valuation. 4. The investigation aims to assess if the offered price undervalues HilleVax. 5. This tender offer requires prompt legal consultation for interested shareholders.